aid: pathalys-pharma name: Pathalys Pharma description: >- Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company headquartered at 4000 Center at North Hills Street, Raleigh, North Carolina, in the Research Triangle Park region. It was created with initial funding from Catalys Pacific and the DaVita Venture Group to be a multi-asset biopharmaceutical company focused on the needs of patients with end-stage kidney disease, and it develops advanced therapeutics addressing unmet needs in the management of late-stage chronic kidney disease (CKD). Its lead asset is upacicalcet, a novel non-peptide calcimimetic delivered intravenously by pre-filled syringe at the end of a hemodialysis session for the treatment of secondary hyperparathyroidism (SHPT) in patients with end-stage kidney disease on hemodialysis; it is an investigational product candidate in the United States, subject to FDA review. Pathalys raised $150 million in secured product financing and equity led by Abingworth in January 2023 alongside a development collaboration with Launch Therapeutics to run the pivotal PATH Phase 3 program, and closed an oversubscribed $105 million Series B in August 2024 to fund NDA submission and pre-commercialization. Pathalys runs no developer program and publishes no product API; the only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind pathalys.com, which serves the corporate site, the news and scientific-updates stream, and the media library. deliveryModel: model: saas open_source: false commercial: true callable_host: true label: Hosted service ยท you call their endpoint confidence: high source: - openapi - pricing generated: '2026-08-28' method: derived image: https://pathalys.com/wp-content/uploads/2021/09/pathalys_logo.svg url: https://raw.githubusercontent.com/api-evangelist/pathalys-pharma/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enriched specificationVersion: '0.23' created: '2026-08-26' modified: '2026-08-26' tags: - Company - Pharmaceuticals - Biotechnology - Nephrology - Chronic Kidney Disease - Clinical Trials - Life Sciences - content-api tags_raw: - Company - pharmaceuticals - biotechnology - nephrology - chronic-kidney-disease - clinical-trials - life-sciences - content-api apis: - aid: pathalys-pharma:pathalys-pharma-posts-api name: Pathalys Pharma Posts API description: Pathalys Pharma news, press releases and scientific updates humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Posts properties: - type: OpenAPI url: openapi/pathalys-pharma-posts-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-pages-api name: Pathalys Pharma Pages API description: Corporate pages โ€” company, team, science, contact and legal humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Pages properties: - type: OpenAPI url: openapi/pathalys-pharma-pages-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-media-api name: Pathalys Pharma Media API description: Media library โ€” logos, team photography and press imagery humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Media properties: - type: OpenAPI url: openapi/pathalys-pharma-media-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-categories-api name: Pathalys Pharma Categories API description: Post categories and tags taxonomy humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Categories properties: - type: OpenAPI url: openapi/pathalys-pharma-categories-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-comments-api name: Pathalys Pharma Comments API description: Comments on posts (collection is empty on this site) humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Comments properties: - type: OpenAPI url: openapi/pathalys-pharma-comments-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-search-api name: Pathalys Pharma Search API description: Cross-content search over posts and pages humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Search properties: - type: OpenAPI url: openapi/pathalys-pharma-search-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - aid: pathalys-pharma:pathalys-pharma-discovery-api name: Pathalys Pharma Discovery API description: Site index, route/namespace table, content types, taxonomies, statuses and oEmbed humanURL: https://developer.wordpress.org/rest-api/ baseURL: https://pathalys.com/wp-json tags: - Discovery properties: - type: OpenAPI url: openapi/pathalys-pharma-discovery-api-openapi.yml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://pathalys.com/ - type: Team url: https://pathalys.com/team/ - type: News url: https://pathalys.com/news/ - type: Science url: https://pathalys.com/scientific-updates/ - type: Blog url: https://pathalys.com/news/ - type: BlogRSS url: https://pathalys.com/feed/ - type: Contact url: https://pathalys.com/contact/ - type: Support url: https://pathalys.com/contact/ - type: PrivacyPolicy url: https://pathalys.com/privacy-policy/ - type: TermsOfService url: https://pathalys.com/terms-of-use/ - type: LinkedIn url: https://www.linkedin.com/company/pathalys - type: SecondaryMarket url: https://forgeglobal.com/pathalys-pharma_stock/ - type: Documentation url: https://developer.wordpress.org/rest-api/ - type: Overlay url: overlays/pathalys-pharma-content-overlay.yaml - type: Authentication url: authentication/pathalys-pharma-authentication.yml - type: Conventions url: conventions/pathalys-pharma-conventions.yml - type: Conformance url: conformance/pathalys-pharma-conformance.yml - type: ErrorCatalog url: errors/pathalys-pharma-problem-types.yml - type: Lifecycle url: lifecycle/pathalys-pharma-lifecycle.yml - type: DataModel url: data-model/pathalys-pharma-data-model.yml - type: DomainSecurity url: security/pathalys-pharma-domain-security.yml - type: Plans url: plans/pathalys-pharma-plans-pricing.yml - type: RateLimits url: rate-limits/pathalys-pharma-rate-limits.yml - type: LLMsTxt url: llms/pathalys-pharma-llms.txt - type: AgentSkill url: skills/_index.yml x-pointer-verification: checked: '2026-08-26' method: HTTP GET with a browser User-Agent, following redirects results: - url: https://pathalys.com/ status: 200 - url: https://pathalys.com/team/ status: 200 - url: https://pathalys.com/news/ status: 200 - url: https://pathalys.com/scientific-updates/ status: 200 - url: https://pathalys.com/contact/ status: 200 - url: https://pathalys.com/privacy-policy/ status: 200 - url: https://pathalys.com/terms-of-use/ status: 200 - url: https://pathalys.com/feed/ status: 200 - url: https://www.linkedin.com/company/pathalys status: 200 - url: https://developer.wordpress.org/rest-api/ status: 200 - url: https://pathalys.com/wp-json/ status: 200 - url: https://forgeglobal.com/pathalys-pharma_stock/ status: 403 note: >- Bot challenge, not a dead page โ€” Forge Global fronts its company pages with an edge policy that refuses non-browser clients. Retained as SecondaryMarket (the harvest source), not as Website. The company's real website is https://pathalys.com/, which the stub previously did not carry. x-enrichment: date: '2026-08-26' status: enriched artifacts_added: 22 pass: local-v1